Itopride 50 mg + Methylpolysiloxane 125 mg Tablet – Manufacturer, Supplier & PCD Franchise



Itopride 50 mg + Methylpolysiloxane 125 mg Tablet — available for PCD franchise from Trumac Healthcare

Itopride 50 mg + Methylpolysiloxane 125 mg Tablet

Itopride 50 mg + Methylpolysiloxane 125 mg — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing

Composition: Itopride 50 mg + Methylpolysiloxane 125 mg
Form: Tablet
Class: Fixed-Dose Combination — Prokinetic agent + Antiflatulent (antifoaming agent)
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ Available Now

Pricing, brochure & monopoly territory within 24 hrs.

Itopride 50 mg + Methylpolysiloxane 125 mg Tablet is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This tablet is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.

Therapeutic Indications
  • Functional dyspepsia with bloating and fullness
  • Nausea, early satiety and upper abdominal discomfort
  • Bloating and flatulence
  • Gas-related abdominal discomfort with dyspepsia
Mechanism of Action

Itopride — Itopride blocks dopamine D2 receptors and inhibits acetylcholinesterase, increasing acetylcholine in the gut wall. This strengthens stomach contractions and speeds gastric emptying.

Methylpolysiloxane — A silicone polymer that lowers the surface tension of gas bubbles in the gut, causing them to merge so trapped gas is passed more easily; it is not absorbed.

Combining these ingredients in one tablet provides complementary action on the target condition and simplifies therapy compared with taking the components separately.

Dosage & Administration
  • Dosage of Itopride 50 mg + Methylpolysiloxane 125 mg Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
  • Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
  • Do not exceed the prescribed dose, and complete the full course as advised.
  • Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
  • To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
  • Diarrhoea or abdominal pain
  • Headache and dizziness
  • Raised prolactin (breast tenderness, galactorrhoea)
  • Generally well tolerated
  • Mild constipation
  • Nausea (rare)
Contraindications
  • Known hypersensitivity to any component of the formulation
  • Gastrointestinal bleeding, obstruction or perforation
  • Pregnancy and breastfeeding
  • Persistent abdominal pain needs medical evaluation
Storage

Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.

Offered by Trumac Healthcare, a PCD pharma franchise company, available on a monopoly basis – see the general range pharma franchise product list (PDF). See our full tablet range for PCD franchise. Comparing companies? See the general range PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.


For chemists, distributors and doctors: need Itopride 50 mg + Methylpolysiloxane 125 mg Tablet for a PCD franchise or wholesale? Trumac Healthcare checks availability with its WHO-GMP certified partner units and quotes on enquiry – no franchise fee; first order from ₹25,000.

WhatsApp your requirement

See the full gastro range – manufacturer, supplier and PCD franchise: pantoprazole, rabeprazole, esomeprazole, vonoprazan, domperidone, ondansetron, sucralfate, antacids, laxatives and liver medicines.

PCD Pharma Franchise & Third Party Manufacturing — Itopride + Methylpolysiloxane Tablet

  • ✓ Made at WHO-GMP certified partner units — every batch QC released
  • ✓ Monopoly PCD franchise rights at district or state level
  • ✓ Third party / contract manufacturing under your own brand
  • ✓ Wholesale and distributor supply against drug licence + GST
  • ✓ Attractive net rates with healthy PTR / PTS margins
  • ✓ Dispatch within 48 hours of payment realisation

Composition: Itopride 50 mg + Methylpolysiloxane 125 mg. It is a fixed-dose combination of prokinetic agent and antiflatulent (antifoaming agent), used for functional dyspepsia with bloating and fullness and bloating and flatulence. Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.

Itopride + Methylpolysiloxane Tablet brings together Itopride (prokinetic agent) and Methylpolysiloxane (antiflatulent) in a single fixed-dose formulation.

PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Itopride + Methylpolysiloxane Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.

Frequently Asked Questions

Who manufactures Itopride + Methylpolysiloxane Tablet in India?

Trumac Healthcare is a supplier of Itopride + Methylpolysiloxane Tablet in India; products are made at WHO-GMP certified partner units. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.

What is Itopride + Methylpolysiloxane Tablet used for?

Itopride + Methylpolysiloxane Tablet is used for functional dyspepsia with bloating and fullness; nausea, early satiety and upper abdominal discomfort; bloating and flatulence; gas-related abdominal discomfort with dyspepsia. It should be used as advised by a registered medical practitioner.

Is Itopride + Methylpolysiloxane Tablet available for PCD pharma franchise on monopoly basis?

Yes. Itopride 50 mg + Methylpolysiloxane 125 mg Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.

Do you offer Itopride + Methylpolysiloxane for third party or contract manufacturing?

Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Itopride + Methylpolysiloxane Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.

Can Itopride + Methylpolysiloxane Tablet be supplied on wholesale or distributor basis?

Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.

What is the therapeutic class of Itopride + Methylpolysiloxane?

Itopride + Methylpolysiloxane is a fixed-dose combination of prokinetic agent and antiflatulent (antifoaming agent) (therapeutic class: Fixed-Dose Combination — Prokinetic agent + Antiflatulent (antifoaming agent)).

What documentation is provided with each supply?

Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.

How quickly can an order be dispatched?

Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.

Is a prescription required for Itopride + Methylpolysiloxane Tablet?

Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.

Ready to start your PCD franchise for Itopride 50 mg + Methylpolysiloxane 125 mg Tablet?

Get Pricing & Franchise Terms →